Top
image credit: Unsplash

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

October 28, 2021

Category:

Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The team – from the University of North Carolina at Chapel Hill Gillings School of Global Public Health, the North Carolina Department of Health and Human Services, and North Carolina State University –reports that the one-dose vaccine regimen developed by Janssen is also highly effective at preventing hospitalizations and deaths.

Read More on Medical News